Farallon Capital Management’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
|
|||||
|
2022
Q4 | $152M | Buy |
|
|||||
|
2022
Q3 | $97.3M | Buy |
|
|||||
|
2022
Q2 | $77.4M | Sell |
|
|||||
|
2022
Q1 | $186M | Sell |
|
|||||
|
2021
Q4 | $218M | Buy |
|
|||||
|
2021
Q3 | $52M | Buy |
|
|||||
|
2021
Q1 | – | Sell |
|
|||||
|
2020
Q4 | $123M | Sell |
|
|||||
|
2020
Q3 | $372M | Buy |
|
|||||
|
2020
Q2 | $407M | Buy |
|
|||||
|
2020
Q1 | $305M | Buy |
|
|||||
|
2019
Q4 | $221M | Buy |
|
|||||
|
2019
Q3 | $75.7M | Buy |
|
|||||
|
2018
Q1 | – | Sell |
|
|||||
|
2017
Q4 | $67.7M | Buy |
|
|||||
|
2017
Q3 | $52M | Sell |
|
|||||
|
2017
Q2 | $60.5M | Buy |
|
|||||
|
2017
Q1 | – | Sell |
|
|||||
|
2016
Q4 | $10M | Buy |
|
|||||
|
2015
Q4 | – | Sell |
|
|||||
|
2015
Q3 | $39.3M | Buy |
|
|||||
|
2015
Q2 | $19.1M | Buy |
|